Filing Flows › Nutex Health (NUTX) › Stock forecast & fair value
Nutex Health (NUTX) stock forecast and price target
Nutex Health (NUTX) trades at $180.56. 6 analysts' median price target is $308.00 (+71%), from $200.00 to $336.00.
Nutex Health's latest quarter
Nutex Health, Q3 2026: revenue $218M (-19% year over year), operating margin 35.4%, net earnings $40.2M, operating cash flow $78.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NUTX stock?
The median of 6 analysts' 12-month targets is $308.00, +71% from $180.56; the range is $200.00 to $336.00. The average rating is strong buy.
Does Nutex Health usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is NUTX stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.